99 related articles for article (PubMed ID: 19002460)
1. Variability in responsiveness to lovastatin of the primitive CD34+ AML subfraction compared to normal CD34+ cells.
de Jonge-Peeters SD; van der Weide K; Kuipers F; Sluiter WJ; de Vries EG; Vellenga E
Ann Hematol; 2009 Jun; 88(6):573-80. PubMed ID: 19002460
[TBL] [Abstract][Full Text] [Related]
2. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
Lu C; Hassan HT
Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
[TBL] [Abstract][Full Text] [Related]
3. Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia.
Moshaver B; van Rhenen A; Kelder A; van der Pol M; Terwijn M; Bachas C; Westra AH; Ossenkoppele GJ; Zweegman S; Schuurhuis GJ
Stem Cells; 2008 Dec; 26(12):3059-67. PubMed ID: 19096043
[TBL] [Abstract][Full Text] [Related]
4. Multiparametric analysis of apoptotic and multi-drug resistance phenotypes according to the blast cell maturation stage in elderly patients with acute myeloid leukemia.
Suárez L; Vidriales B; García-Laraña J; López A; Martínez R; Martín-Reina V; Tormo M; González-San Miguel JD; Lavilla E; García-Boyero R; Orfao A; San Miguel JF;
Haematologica; 2001 Dec; 86(12):1287-95. PubMed ID: 11726321
[TBL] [Abstract][Full Text] [Related]
5. Primitive AML progenitors from most CD34(+) patients lack CD33 expression but progenitors from many CD34(-) AML patients express CD33.
Vercauteren S; Zapf R; Sutherland H
Cytotherapy; 2007; 9(2):194-204. PubMed ID: 17453971
[TBL] [Abstract][Full Text] [Related]
6. Functional alterations of Lin-CD34+CD38+ cells in chronic myelomonocytic leukemia and on progression to acute leukemia.
Sun Q; So CC; Yip SF; Wan TS; Ma SK; Chan LC
Leuk Res; 2008 Sep; 32(9):1374-81. PubMed ID: 18372040
[TBL] [Abstract][Full Text] [Related]
7. The effect of the proteasome inhibitor bortezomib on acute myeloid leukemia cells and drug resistance associated with the CD34+ immature phenotype.
Colado E; Alvarez-Fernández S; Maiso P; Martín-Sánchez J; Vidriales MB; Garayoa M; Ocio EM; Montero JC; Pandiella A; San Miguel JF
Haematologica; 2008 Jan; 93(1):57-66. PubMed ID: 18166786
[TBL] [Abstract][Full Text] [Related]
8. Combining simvastatin with the farnesyltransferase inhibitor tipifarnib results in an enhanced cytotoxic effect in a subset of primary CD34+ acute myeloid leukemia samples.
van der Weide K; de Jonge-Peeters SD; Kuipers F; de Vries EG; Vellenga E
Clin Cancer Res; 2009 May; 15(9):3076-83. PubMed ID: 19383813
[TBL] [Abstract][Full Text] [Related]
9. Differences in anti-apoptotic and multidrug resistance phenotypes in elderly and young acute myeloid leukemia patients are related to the maturation of blast cells.
Suárez L; Vidriales MB; Moreno MJ; López A; García-Laraña J; Pérez-López C; Tormo M; Lavilla E; López-Berges MC; de Santiago M; San Miguel JF; Orfao A;
Haematologica; 2005 Jan; 90(1):54-9. PubMed ID: 15642669
[TBL] [Abstract][Full Text] [Related]
10. Defective in vitro growth of primitive hematopoietic cells from pediatric patients with acute myeloid leukemia.
Dorantes-Acosta E; Chávez-González A; Santos JI; Medina-Sanson A; Mayani H
Pediatr Blood Cancer; 2008 Dec; 51(6):741-6. PubMed ID: 18680148
[TBL] [Abstract][Full Text] [Related]
11. CD34 expression in native human acute myelogenous leukemia blasts: differences in CD34 membrane molecule expression are associated with different gene expression profiles.
Oyan AM; Bø TH; Jonassen I; Ulvestad E; Gjertsen BT; Kalland KH; Bruserud O
Cytometry B Clin Cytom; 2005 Mar; 64(1):18-27. PubMed ID: 15668952
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling in the leukemic stem cell-enriched CD34+ fraction identifies target genes that predict prognosis in normal karyotype AML.
de Jonge HJ; Woolthuis CM; Vos AZ; Mulder A; van den Berg E; Kluin PM; van der Weide K; de Bont ES; Huls G; Vellenga E; Schuringa JJ
Leukemia; 2011 Dec; 25(12):1825-33. PubMed ID: 21760593
[TBL] [Abstract][Full Text] [Related]
13. Differences between the CD34+ and CD34- blast compartments in apoptosis resistance in acute myeloid leukemia.
van Stijn A; van der Pol MA; Kok A; Bontje PM; Roemen GM; Beelen RH; Ossenkoppele GJ; Schuurhuis GJ
Haematologica; 2003 May; 88(5):497-508. PubMed ID: 12745269
[TBL] [Abstract][Full Text] [Related]
14. Nm23-h1 indirectly promotes the survival of acute myeloid leukemia blast cells by binding to more mature components of the leukemic clone.
Lilly AJ; Khanim FL; Hayden RE; Luong QT; Drayson MT; Bunce CM
Cancer Res; 2011 Feb; 71(3):1177-86. PubMed ID: 21169412
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the normal or leukemic nature of CD34+ cells in acute myeloid leukemia with low percentages of CD34 cells.
van der Pol MA; Feller N; Roseboom M; Moshaver B; Westra G; Broxterman HJ; Ossenkoppele GJ; Schuurhuis GJ
Haematologica; 2003 Sep; 88(9):983-93. PubMed ID: 12969806
[TBL] [Abstract][Full Text] [Related]
16. Positive selection for CD90 as a purging option in acute myeloid leukemia stem cell transplants.
Feller N; Kelder A; Westra G; Ossenkoppele GJ; Schuurhuis GJ
Cytometry B Clin Cytom; 2008 Jan; 74(1):9-16. PubMed ID: 18061946
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia].
Liu YR; Wang YZ; Chen SS; Chang Y; Fu JY; Li LD; Wang H; Yu H; Jiang B; Huang XJ
Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):731-6. PubMed ID: 18457262
[TBL] [Abstract][Full Text] [Related]
18. Selective inhibition of primary acute myeloid leukaemia cell growth by lovastatin.
Newman A; Clutterbuck RD; Powles RL; Millar JL
Leukemia; 1994 Feb; 8(2):274-80. PubMed ID: 8309251
[TBL] [Abstract][Full Text] [Related]
19. Mucin1 expression is enriched in the human stem cell fraction of cord blood and is upregulated in majority of the AML cases.
Fatrai S; Schepers H; Tadema H; Vellenga E; Daenen SM; Schuringa JJ
Exp Hematol; 2008 Oct; 36(10):1254-65. PubMed ID: 18640764
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of bone marrow and peripheral blood CD34+ myeloblasts in acute myeloid leukaemia.
Cheung AM; Chow HC; Liang R; Leung AY
Br J Haematol; 2009 Feb; 144(4):484-91. PubMed ID: 19055666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
